Biological enhancement of tibial diaphyseal aseptic non-unions: the efficacy of autologous bone grafting, BMPs and reaming by-products
- PMID: 17920420
- DOI: 10.1016/s0020-1383(07)80011-8
Biological enhancement of tibial diaphyseal aseptic non-unions: the efficacy of autologous bone grafting, BMPs and reaming by-products
Erratum in
- Injury. 2007 Oct;38(10):1224
Abstract
The mandatory stimulus that can optimise the healing pathway can be electrical, mechanical, biological, or a combination of all these parameters. A variety of means has been utilised for biological enhancement, including extracorporeal shock wave, electrical, ultrasound stimulation, the reaming technique of IM nailing, bone graft substitutes, osteogenic cells and bioactive molecules produced by tissue engineering techniques. The aim of this study is to present a review of the existing evidence for the efficacy of reaming, autologous bone grafting and the commercially available growth factors (BMP-2 and BMP-7) for the treatment of aseptic tibial non-unions. The gold standard method of enhancing bone healing in cases of tibial non-union remains the autologous bone graft. Autogenous bone grafts possess osteoconductive, osteoinductive properties and also osteoprogenitor cells. However, their harvesting is associated with high morbidity and many complications reaching percentages of 30%. Intramedullary reamed nailing, either used as an alternative fixation method or as an exchange to a wider implant, offers the unique biomechanical advantages of an intramedullary device, together with the osteoinductive stimulus of the by-products of reaming, and the aptitude for early weight-bearing and active rehabilitation. The safety of administration of the commercial distributed growth factors (BMP-2 and BMP-7), combined with the lack of the morbidity and the quantity restrictions that characterise autologous bone grafts, have given to this family of molecules a principal role between the other bone graft substitutes. On average the union rates reported in the 20 manuscripts that have been evaluated range from 58.3% to 100%, and the average time to union from 12.5 weeks to 48.4 weeks, indicating the significant discrepancies in the reported evidence and the multiplicity of different treatment strategies.
Similar articles
-
Osteogenic protein-1 for long bone nonunion: an evidence-based analysis.Ont Health Technol Assess Ser. 2005;5(6):1-57. Epub 2005 Apr 1. Ont Health Technol Assess Ser. 2005. PMID: 23074475 Free PMC article.
-
Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions.J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 2):S151-8. J Bone Joint Surg Am. 2001. PMID: 11314793 Free PMC article. Clinical Trial.
-
Recombinant human bone morphogenetic protein-2: a novel osteoinductive alternative to autogenous bone graft?Acta Orthop Belg. 2005 Apr;71(2):133-48. Acta Orthop Belg. 2005. PMID: 16152845 Review.
-
External fixation of tibial pilon fractures and fracture healing.Acta Orthop Suppl. 2007 Jun;78(326):3, 5-34. Acta Orthop Suppl. 2007. PMID: 17465283
-
Treatment of aseptic non-union after intramedullary nailing without removal of the nail.Injury. 2017 Jun;48 Suppl 1:S76-S81. doi: 10.1016/j.injury.2017.04.022. Epub 2017 May 6. Injury. 2017. PMID: 28487102 Review.
Cited by
-
Rap system of stress stimulation can promote bone union after lower tibial bone fracture: a clinical research.Int J Med Sci. 2012;9(6):462-6. doi: 10.7150/ijms.4242. Epub 2012 Jul 31. Int J Med Sci. 2012. PMID: 22859907 Free PMC article. Clinical Trial.
-
Surgical treatment of aseptic forearm nonunion with plate and opposite bone graft strut. Autograft or allograft?Int Orthop. 2015 Jul;39(7):1343-9. doi: 10.1007/s00264-015-2718-6. Epub 2015 Mar 18. Int Orthop. 2015. PMID: 25776465
-
Effects of Bone Morphogenetic Protein-2 on Neovascularization During Large Bone Defect Regeneration.Tissue Eng Part A. 2019 Dec;25(23-24):1623-1634. doi: 10.1089/ten.TEA.2018.0326. Epub 2019 Jun 14. Tissue Eng Part A. 2019. PMID: 30973074 Free PMC article.
-
Comparative Analysis of Stromal Vascular Fraction and Alternative Mechanisms in Bone Fracture Stimulation to Bridge the Gap between Nature and Technological Advancement: A Systematic Review.Biomedicines. 2024 Feb 1;12(2):342. doi: 10.3390/biomedicines12020342. Biomedicines. 2024. PMID: 38397944 Free PMC article. Review.
-
Systemically delivered insulin-like growth factor-I enhances mesenchymal stem cell-dependent fracture healing.Growth Factors. 2012 Aug;30(4):230-41. doi: 10.3109/08977194.2012.683188. Epub 2012 May 4. Growth Factors. 2012. PMID: 22559791 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical